Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.
2.

CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.

Mitra P, Yang RM, Sutton J, Ramsay RG, Gonda TJ.

Oncotarget. 2016 Feb 23;7(8):9069-83. doi: 10.18632/oncotarget.6997.

3.

MYB suppresses differentiation and apoptosis of human breast cancer cells.

Drabsch Y, Robert RG, Gonda TJ.

Breast Cancer Res. 2010;12(4):R55. doi: 10.1186/bcr2614.

4.

c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression.

Thompson MA, Rosenthal MA, Ellis SL, Friend AJ, Zorbas MI, Whitehead RH, Ramsay RG.

Cancer Res. 1998 Nov 15;58(22):5168-75.

5.
6.

TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.

Cesi V, Casciati A, Sesti F, Tanno B, Calabretta B, Raschellà G.

Cell Cycle. 2011 Dec 1;10(23):4149-61. doi: 10.4161/cc.10.23.18346.

PMID:
22101269
7.

Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo.

Danbara N, Yuri T, Tsujita-Kyutoku M, Tsukamoto R, Uehara N, Tsubura A.

Anticancer Res. 2005 May-Jun;25(3B):2269-76.

8.

Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells.

Choi KC, Kang SK, Tai CJ, Auersperg N, Leung PC.

Endocrinology. 2001 Jun;142(6):2351-60.

PMID:
11356682
9.

Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice.

Cho SJ, Kim JS, Kim JM, Lee JY, Jung HC, Song IS.

Int J Cancer. 2008 Aug 15;123(4):951-7. doi: 10.1002/ijc.23593.

10.

Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.

Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC.

J Natl Cancer Inst. 2005 Dec 7;97(23):1746-59.

PMID:
16333030
11.
12.

Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.

Raha P, Thomas S, Thurn KT, Park J, Munster PN.

Breast Cancer Res. 2015 Feb 25;17:26. doi: 10.1186/s13058-015-0533-z.

13.

Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.

Rossi V, Bellastella G, De Rosa C, Abbondanza C, Visconti D, Maione L, Chieffi P, Della Ragione F, Prezioso D, De Bellis A, Bellastella A, Sinisi AA.

J Cell Physiol. 2011 May;226(5):1334-9. doi: 10.1002/jcp.22461.

PMID:
20945400
14.
15.

Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells.

Tomasi ML, Ryoo M, Ramani K, Tomasi I, Giordano P, Mato JM, Lu SC.

Oncotarget. 2015 Nov 10;6(35):37706-23. doi: 10.18632/oncotarget.5342.

16.

Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.

Greco C, Alvino S, Buglioni S, Assisi D, Lapenta R, Grassi A, Stigliano V, Mottolese M, Casale V.

Anticancer Res. 2001 Sep-Oct;21(5):3185-92.

PMID:
11848471
17.
19.

Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice.

Kang HW, Kim JM, Cha MY, Jung HC, Song IS, Kim JS.

Dig Dis Sci. 2012 Nov;57(11):2873-82. doi: 10.1007/s10620-012-2237-x.

PMID:
22623043
20.

A dominant interfering Myb mutant causes apoptosis in T cells.

Taylor D, Badiani P, Weston K.

Genes Dev. 1996 Nov 1;10(21):2732-44.

Supplemental Content

Support Center